Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.
NCT01232244 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2013-12-10
Summary
Tiny molecules (hormones) are released from the bowels and other organs to the bloodstream in response to meals in order to orchestrate the metabolism. Oxyntomodulin, GLP-1 and glucagon are all known to regulate parameters such as appetite, food intake and induce weight loss.
Therefore we want to investigate mechanistic relations between the three hormones.
Conditions
- Incretin Action
- Obesity
Interventions
- OTHER
-
GLP-1 infusion
1 pmol/kg/min
- OTHER
-
Glucagon infusion
3ng/kg/min
- OTHER
-
Oxyntomodulin infusion
3 pmol/kg/min
- OTHER
-
GLP-1 and glucagon infusion
1 pmol/kg/min 3 ng/kg/min
- OTHER
-
Placebo
NaCl 9 g/L infusion
Sponsors & Collaborators
-
University Hospital, Gentofte, Copenhagen
lead OTHER
Principal Investigators
-
Jonatan I Bagger, MD · Gentofte University Hospital, University of Copenhagen
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-01-31
- Completion
- 2012-01-31
Countries
- Denmark
Study Locations
More Related Trials
-
Effects of Intravenous Infusions of Gut Hormones on Appetite and Metabolism.
NCT00940134 ·Status: COMPLETED ·Phase: NA
-
The Interaction Between Appetite Hormones
NCT02094183 ·Status: COMPLETED ·Phase: NA
-
Effects of Glucagon Administration on Energy Expenditure
NCT02237053 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Intact Vagal Innervation and Glucagon-like Peptide-1 (GLP-1) Effects
NCT01176890 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of GIP, GLP-1 and GLP-2 in Individuals With Genetically Altered Receptor Function
NCT06194955 ·Status: COMPLETED ·Phase: NA
-
Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)
NCT06774807 ·Status: COMPLETED ·Phase: NA
-
Direct Versus Indirect Effect of Amino Acids on Hepatokines
NCT06240039 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hyperglycemia and the Extra-pancreatic Effect of Incretins
NCT01749163 ·Status: COMPLETED ·Phase: NA
-
Peripheral Metabolic Effects of Ghrelin
NCT00771940 ·Status: COMPLETED ·Phase: PHASE1
-
-Oleoyl Glycerol is a GPR119 Agonist and Signals GLP-1 Release in Humans.
NCT01043445 ·Status: COMPLETED ·Phase: NA
-
Separate and Combined Extrapancreatic Effects of GIP and GLP-1
NCT06895408 ·Status: COMPLETED ·Phase: NA
-
GLP-1's Effect on Cardiac Parameters and Mesenteric Blood Flow
NCT01988545 ·Status: UNKNOWN ·Phase: NA
-
GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
NCT00264199 ·Status: COMPLETED ·Phase: NA
-
Fat-induced Release of GLP-1 in Humans
NCT02264951 ·Status: COMPLETED ·Phase: NA
-
Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects
NCT03682172 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effects of Oral vs Intravenous Glucose Administration on Novel Candidates of Energy Regulation
NCT04888325 ·Status: COMPLETED ·Phase: NA
-
Effects of Gut Peptides on Bone Remodeling
NCT03574064 ·Status: COMPLETED ·Phase: NA
-
Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response
NCT01534442 ·Status: UNKNOWN ·Phase: NA
-
Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines
NCT03241303 ·Status: COMPLETED ·Phase: NA
-
GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake
NCT02598791 ·Status: COMPLETED ·Phase: NA
-
Investigation of GLP-2 Mechanism of Action (GA-8)
NCT03159741 ·Status: COMPLETED ·Phase: NA
-
Effect of GLP-1 on Postprandial Lipid Metabolism
NCT01760772 ·Status: UNKNOWN ·Phase: NA